Mobilization of CD34+CXCR4+ Stem/Progenitor Cells and the Parameters of Left Ventricular Function and Remodeling in 1-Year Follow-up of Patients with Acute Myocardial Infarction

Table 1

Characteristics of the study group.

	CTRL (𝑛=20)	SAP (𝑛=28)	AMI (𝑛=50)	P
Age (years) (mean ± SD)	44,6 ± 6,2	56,7 ± 11,6	58 ± 11,5	𝑃<0.05 versus CTRL
Age (years) (median ± IQR)	44 (34–54)	56 (32–75)	57 (30–79)	𝑃<0.05 versus CTRL
Male, n (%)	17 (57)	18 (60)	30 (60)	P = NS
Hypertension, n (%)	7 (23)	17 (57)	30 (60)	𝑃<0.05 versus CTRL
Hypercholesterolaemia, n (%)	8 (26)	23 (77)	35 (70)	𝑃<0.05 versus CTRL
Type 2 diabetes mellitus, n (%)	0	11 (36)	18 (36)	𝑃<0.05 versus CTRL
Smoking, n (%)	12 (40)	19 (63)	32 (64)	𝑃<0.05 versus CTRL
Family history of IHD, n (%)	8 (27)	13 (43)	24 (48)	𝑃<0.05 versus CTRL
Statins prior to hospitalization, n (%)	0	20 (67)	32 (64)	𝑃<0.05 versus CTRL
ACE inhibitors, n (%)	4 (13)	16 (53)	23 (46)	𝑃<0.05 versus CTRL
Acetylsalicylic acid, n (%)	2 (7)	28 (100)	31 (62)	𝑃<0.05 versus CTRL, SAP
Total cholesterol [mg/dL]	199 (156–256)	201 (156–256)	201,5 (122–313)	P = NS
HDL cholesterol [mg/dL]	43 (20–70)	43 (24–75)	41 (13–74)	P = NS
LDL Cholesterol [mg/dL]	97 (89–124)	100 (65–216)	105 (65–113)	P = NS
Triglycerides [mg/dL]	150 (123–200)	176,5 (84–269)	163 (76–375)	P = NS
Creatinine [mg/dL]	0,9 (0,7–1,4)	0,9 (0,8–1,3)	0,9 (0,7–14)	P = NS
Erythrocytes [×10^6/μL]	4,7 (4,2–5,1)	4,7 (4,3–5,1)	4,62 (4,12–5,2)	P = NS
Leucocytes [×10^3/μL]	6,9 (5,5–8,3)	6,6 (5,2–7,4)	10,17 ± 2,8	𝑃<0.001 versus CTRL, SAP
Monocytes [×10^3/μL]	0,8 (0,4–1,2)	0,7 (0,46–1,14)	0,76 (0,41–1,1)	P = NS
Platelets [×10^3/μL]	195 (143–246)	194 (137–251)	198 (146–250)	P = NS
Initial LVEF ≤40%, n (%)	—	—	14 (28)
Initial CKMB [U/l]	—	—	26,5 (5–136)
Initial TnI [ng/mL]	—	—	0,7 (0,0–18)
Maximal CKMB [U/l]	—	—	109,5 (5–572)
Maximal TnI [ng/mL]	—	—	4,7 (0,92–72)
Anterior wall infarction, n (%)	—	—	30 (60)
Multivessel CAD, n (%)	—	—	26 (52)